Innate immunity
[대역어] 선천면역
[용어속성] Term
[용어속성] Term
Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets
패혈증 관련 사이토카인 폭풍의 유료 유사 수용체 및 미래 면역 조절 표적으로서의 내인성 음성 조절자
Review
[키워드] activate
Activation
acute infections
Acute inflammation
cells
chemokines
COVID-19
cytokine
Cytokine storm
Cytokines
damage
DAMPs
death
Diseases
downstream signaling pathway
downstream signaling pathways
expressed
generate
Genetic
Host
host cells
host cells)
Immune cell
immune cells
Immune homeostasis
immunomodulatory
implicated
include
induction
inflammatory conditions
Inflammatory diseases
Inflammatory response
Innate
Innate immunity
interferons
lead
maintain
MAMP
MAMPs
mechanism
mechanisms
mediators
MODS
molecular pattern
multi-organ dysfunction
multi-organ failure
negative feedback
negative feedback mechanisms
neurons
nitrogen
non-immune
organ dysfunction
oxygen
PAMPs
pandemic
pathogen
Pathogens
Pathways
Pattern recognition
pattern recognition receptor
persistence
pro-inflammatory mediator
pro-inflammatory mediators
PRRs
reactive oxygen
Recognition
recognize
released
repair
ROS
Sepsis
severe COVID-19
subject
syndrome
systemic inflammatory
target
the patient
therapeutic drug
TLR
TLR signaling
TLR signaling pathways
TLRs
Toll-like receptor
Toll-like receptors
[DOI] 10.1016/j.intimp.2020.107087 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.intimp.2020.107087 PMC 바로가기 [Article Type] Review
Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis
Review Article
[키워드] acute respiratory distress
acute respiratory syndrome
addition
Affect
airway epithelia
aspergillosis
Aspergillus fumigatus
asymptomatic infection
caused
changes
Clinical course
clinical manifestation
complex
conducted
coronavirus
COVID-19
described
disease
domain
enzyme
expressed
Factors
fungal
immune regulation
immune responses
immunological mechanism
Inflammatory response
Influenza
information
Innate immunity
Interaction
invasive
involved
lung parenchyma
mechanical ventilation
pandemic coronavirus
Patient
patients with COVID-19
persistence
Protective
pulmonary impairment
receptor
reported
response
SARS-CoV-2
syndrome
[DOI] 10.18502/cmm.6.4.5442 PMC 바로가기 [Article Type] Review Article
[DOI] 10.18502/cmm.6.4.5442 PMC 바로가기 [Article Type] Review Article
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
Clinical Trial
[키워드] anti-SARS-CoV-2
antibody
antibody production
approved
B cell
Baricitinib
blood cell
change
circulating
Clinical outcome
clinically
coronavirus disease
correlated
COVID-19
cytokine level
cytokine release
develop
Disabled
evaluated
Evidence
expression
extreme
fraction
frequencies
functional
IL-1β
IL-6
immune
immune dysregulation
Immune phenotype
Immunity
immunology
increase in
Inflammatory response
Innate
Innate immunity
JAK/STAT signaling
Local
lymphopenia
modulating
myeloid cell
need for oxygen
off-label
oxygen
P/F
PaO2
Pathways
Patient
patients treated
patients with COVID-19
per day
phosphorylated
Pneumonia
prevented
progression
reduction in
regulated
Serum level
severe COVID-19
Spike protein
STAT3
supported
the patient
the SARS-CoV-2
therapy
TNF-α
transcriptionally
treated
Trial
viral disease
[DOI] 10.1172/JCI141772 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1172/JCI141772 PMC 바로가기 [Article Type] Clinical Trial
Does eNOS derived nitric oxide protect the young from severe COVID-19 complications?
eNOS 유래 산화질소는 심각한 COVID-19 합병증으로부터 젊은이를 보호합니까?
Review
[키워드] activated
Activation
age
Anti-viral
Antiviral
Asian
barrier
bradykinin
Bradykinin (BK)
Cell
change
Complication
complications
COVID-19
COVID-19 mortality
COVID-19 pandemic
COVID-19 patient
COVID-19 patients
death
Decline
decrease
disease
Disease progression
disparity
endothelial
Endothelial cell
endothelial cells
Endothelial cells (ECs)
Endothelial dysfunction
Endothelial nitric oxide synthase (eNOS)
explain
Haplotype
IFN
increased risk
Inflammation
inhibit
Innate immunity
interferon
inverse correlation
lead
mechanism
molecular mechanism
molecular mechanisms
nitric oxide
Nitric oxide (NO).
nitric oxide synthase
NO production
observation
occur
progression
PROTECT
provide
respiratory
SARS-CoV-1
severe COVID-19
severe disease
severe patients
shown
the interferon
the patient
type I
type I and III IFNs
vascular disease
Viral
viruses
Vitamin
Vitamin D
[DOI] 10.1016/j.arr.2020.101201 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.arr.2020.101201 PMC 바로가기 [Article Type] Review
Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review
기저 면역 결핍이 있는 COVID-19 사례에서 숙주 면역 및 염증 반응의 역할: 검토
Review
[키워드] acute respiratory syndrome
anti-infection
Anti-inflammatory
Antiviral
characterized
Comorbidities
coronavirus
Coronavirus disease 2019
COVID-19
cytokine release
Cytokine release syndrome
Cytokine storm
Cytokine storm syndrome
deficiency
disease severity
higher risk
IFNAR2
Immune status
immune system
immunodeficiency
immunomodulatory effects
Inflammatory response
innate immune
innate immune activation
Innate immunity
interferon regulatory factor
interferon signaling
Intravenous immunoglobulin
IVIG
literature review
outcome
pandemic
Patient
patient population
patients
PID
Primary Immunodeficiency
protective effect
protective factor
question
receptor
response
review
role
SARS-CoV-2
SARS-COV-2 infection
severe COVID-19
severe infections
Signaling
Spread
suppressed
susceptible
therapy
TLR7
[DOI] 10.1089/jir.2020.0210 PMC 바로가기 [Article Type] Review
[DOI] 10.1089/jir.2020.0210 PMC 바로가기 [Article Type] Review
Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates
SARS-CoV-2에 감염된 비인간 영장류에서 급성, 해결 또는 진행성 COVID-19의 세포 사건
Article
[키워드] accumulation
acute phase
animals
anti-inflammatory response
anti-inflammatory responses
association
CCL17
CD11b
CD11c
CD16
Cell
cell population
Cellular immune response
cellular mechanism
cellular mechanisms
COVID-19
detectable
develop
disease
event
expressing
heterogeneous
HLA-DR
identify
IL-10
IL-6
IL-6 level
IL-6 levels
immune
Infection
infiltration
Innate immunity
interstitial
Kynurenine
less
long-lasting
lung
Lungs
Macrophage
macrophages
Migration
Mild
monocyte
Monocytes
Neutrophils
NHP
non-human primate
non-human primates
outcome
pathology
plasma
progressive COVID-19
Pulmonary pathology
robust
SARS-CoV-2
SARS-COV-2 infection
subset
subtype
Therapies
Tryptophan
understanding
Vaccine
Viral
Viral load
viral replication
[DOI] 10.1038/s41467-020-19967-4 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-020-19967-4 PMC 바로가기 [Article Type] Article
Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
Review
[키워드] 2019-nCoV
acute respiratory distress
against SARS-CoV
Analysis
Cell
coronavirus
cough
country
COVID-19
COVID-19 pandemic
Developing
development
Dyspnea
Epidemiology
Fever
generate
Healthcare system
Human
human coronavirus
indicate
infected with SARS-CoV-2
Infectious disease
Innate immunity
lung pathogenesis
management
MERS
MERS-CoV
mild cases
modeling
molecular
Multiple
outbreak
Phylogeny
Pneumonia
prevention
provided
regions
responsible
SARS-CoV
SARS-CoV-2
SARS-CoV-2 entry
similarity
Spread
Symptom
syndrome
target
therapy
Transmission
understanding
unique
Vaccine
Vaccine development
variants of SARS-CoV-2
viral replication
virus
Wuhan, China
[DOI] 10.3390/pathogens9120985 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/pathogens9120985 PMC 바로가기 [Article Type] Review
Data, Reagents, Assays and Merits of Proteomics for SARS-CoV-2 Research and Testing
Research
[키워드] A549
ACE2
African green monkey
Analysis
approach
BRCA1
Breast cancer
Caco-2
Calu-3
can be used
cause
cell line
change
changed
Chlorocebus
clinical proteomics
Cohort
COVID-19
COVID-19 pandemic
COVID-19 research
diagnostic
diagnostics
evaluate
Evidence
expression
expression data
facilitate
Factor
feasibility
genomes
globe
Innate immunity
involved
kDa
label-free quantification
manuscript
mass spectrometry
monitoring
parallel reaction monitoring
peer-reviewed
peptides
positive
profile
protease inhibitors
Protein
protein expression
Proteins
proteome
proteomic
proteomics
Region
representing
Research
SARS-CoV-2
SARS-CoV-2 cell
SARS-COV-2 infection
SARS-CoV-2 proteins
SARS-CoV-2 research
Spread
SRP9
stable-isotope labeling
supernatant
synthetic
synthetic peptide
targeted mass spectrometry
Testing
TMPRSS2
transcriptional regulators
Vero Cell
Vero E6
Vero E6 cell
viral entry
viral infection
virus
widespread
[DOI] 10.1074/mcp.RA120.002164 PMC 바로가기 [Article Type] Research
[DOI] 10.1074/mcp.RA120.002164 PMC 바로가기 [Article Type] Research
Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
administer
Administered
allergic
Analysis
Asparagus
automatically
Ayurveda
CAM
CAP
Capsule
clinical
coded
COVID
COVID 19
COVID-19
COVID-19 positive patient
CTRI
Date
declining
dissemination
Dizziness
dose
double blind
drop-outs
early recovery
Efficacy
element
eligible
Embelia
enrolled
enrolment
exploratory
Follow-up
function
ginger
glycyrrhiza
Health
health condition
Herbal
Herbo-mineral
IL6
IMPROVE
in viral
India
Infection
Innate immunity
Intervention
intervention group
investigator
Last
Medicine
Memorial
Mild
moderate
number
objective
outcome
parallel group
participant
Patient
patients with COVID-19
positive
positive patient
positive RT-PCR
product
protocol
racemosus
randomised
randomised controlled trial
Randomized
Rash
recruitment
reducing
Registered
registration number
registry
Safe
Safety
Sample size
screened
secondary
Shankha
status
study period
Study protocol
submission
Test
Th17
the disease
the placebo group
Treatment
Trial
two group
two groups
Viral load
website
were blinded
Zinc
Zingiber
[DOI] 10.1186/s13063-020-04906-x PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04906-x PMC 바로가기 [Article Type] Letter